As per our report, the size of the European Biomaterials Market was worth USD 27693 Million in 2020 and estimated to be growing at a CAGR of 14.30%, to reach USD 54020 Million by 2025.
The recent upsurge in the use of biomaterials is mainly attributed to the tremendous research on advancements in medical technology for the efficient functionality of medical implants. Concerns of biocompatibility and demand for superior implant mechanical performance have added to the need for progress in medical technology.
Increase in government grants and funding, and extensive usage of polymer in biomaterials are some of the factors driving the growth of Europe biomaterials market. Further, with the escalation in the number of geriatric patients, the demand for usage of biomaterials in cardiology, wound healing, neurology and plastic surgery is also on the rise. Besides, new technologies such as hydrogen scaffolding and decellularized dermal matrixes for grafting will also contribute to strong market growth.
However, adverse reaction to biomaterial implants, inflammation and fracture issues, high cost associated with and difficulties in manufacturing are the significant factors off-putting the growth for Europe biomaterials market.
This research report segmented and sub-segmented the European biomaterials market into the following categories:
Some of the key players in the Europe biomaterials market include Royal DSM, Zimmer Biomet Holdings, Inc., Evonik Industries AG, Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Material type
5.1.1 Ceramic
5.1.2 Metallic
5.1.3 Polymer
5.1.4 Natural
5.2 By Application
5.2.1 Orthopaedic
5.2.2 Dental
5.2.3 Cardiovascular
5.2.4 Plastic surgery
5.2.5 Wound healing
5.2.6 Ophthalmology
5.2.7 Tissue engineering
5.2.8 Neurological
5.2.9 Others
6. Geographical Analysis
6.1 Introduction
6.2 U. K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Collagen Matrix, Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Zimmer Biomet Holdings, Inc
8.3 Evonik Industries AG
8.4 Wright Medical Technology, Inc.,
8.5 Corbion N.V
8.6 Berkeley Advanced Biomaterials
8.7 Bayer AG
8.8 Carpenter Technology Corporation
8.9 Covalon Technologies Ltd.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
